Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection. (April 2018)

• Record Type: Journal Article
• Authors: Kang, Inkyung; Chang, Mary Y.; Wight, Thomas N.; Frevert, Charles W.
• Other Names: Schaefer Liliana guest-editor.; Frevert Charles W. guest-editor.
• Is Part Of: Journal of histochemistry and cytochemistry. Volume 66:Number 4(2018:Apr.)
• Page Start: 241
• Page End: 259
• Publication Date: 2018-04
• Subjects: extracellular matrix -- innate immunity -- pulmonary inflammation -- versican; Histochemistry -- Periodicals; Cytochemistry -- Periodicals; Histocytochemistry -- methods; Histological Techniques; 572.05
• DOI: 10.1369/0022155417751880
• Languages: English
• ISSNs: 0022-1554

Abstract

Proteoglycans (PGs) are complex, multifaceted molecules that participate in diverse interactions vital for physiological and pathological processes. As structural components, they provide a scaffold for cells and structural organization that helps define tissue architecture. Through interactions with water, PGs enable molecular and cellular movement through tissues. Through selective ionic interactions with growth factors, chemokines, cytokines, and proteases, PGs facilitate the ability of these soluble ligands to regulate intracellular signaling events and to influence the inflammatory response. In addition, recent findings now demonstrate that PGs can activate danger-associated molecular patterns (DAMPs) and other signaling pathways to influence production of many of these soluble ligands, indicating a more direct role for PGs in influencing the immune response and tissue inflammation. This review will focus on PGs that are selectively expressed during lung inflammation and will examine the novel emerging concept of PGs as immunomodulatory regulators of the innate immune responses in lungs.